-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio Wins Conditional Nasdaq Listing Extension Amid Bid-Price Noncompliance

PUBT·11/16/2026 11:18:45
Listen to the news
Kala Bio Wins Conditional Nasdaq Listing Extension Amid Bid-Price Noncompliance
  • Nasdaq's hearings panel on November 13, 2026, conditionally extended Kala Bio's listing despite its failure to meet minimum bid-price requirements.
  • The company must achieve a closing bid price of at least $1 for 10 consecutive business days by November 30, 2026.
  • Its closing bid price must remain at least $1 each trading day thereafter through February 23, 2027.
  • Any other listing violation before that deadline triggers seven days to submit a remediation plan; the panel could grant relief or delist.
  • If compliance continues through February 23, 2027, the panel intends to impose a discretionary monitor for the following year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-012439), on November 16, 2026, and is solely responsible for the information contained therein.